Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma

• Main Authors: Lei Jiang (Author), Luan Li (Author), Yongzhuang Liu (Author), Meixiao Zhan (Author), Ligong Lu (Author), Shengtao Yuan (Author), Yanyan Liu (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer, and it usually occurs following chronic liver disease. Although some progress has been made in the treatment of HCC, the prognosis of patients with advanced HCC is not optimistic, mainly because of the inevitable develop...